Back to Search
RICHARD GLAZER, DMD
DMD
Oral and Maxillofacial Surgery (Dentist)
NPI: 1497815542Individual
Specialties, Licenses & Credentials
Oral and Maxillofacial Surgery (Dentist)Primary
Dentist — Oral and Maxillofacial Surgery
Code: 1223S0112X
2036(AZ)
Research & Publications (20)
Musashi1: a stem cell marker no longer in search of a function.
PMID 18719393·Cell Cycle·2008
6-review
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
PMID 19470877·Hypertension·2009
2-rct
Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy.
PMID 19192976·Curr Med Res Opin·2009
4-observational
Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study.
PMID 19210151·Curr Med Res Opin·2009
4-observational
Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.
PMID 19147585·Cancer Res·2009
7-preclinical
c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells.
PMID 19363595·Mol Cell Biochem·2009
8-other
A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1.
PMID 19443706·Am J Pathol·2009
7-preclinical
A new mechanism of SOX9 action to regulate PKCalpha expression in the intestine epithelium.
PMID 19509063·J Cell Sci·2009
7-preclinical
Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
PMID 18593517·Curr Med Res Opin·2008
4-observational
Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.
PMID 18362162·Mol Cell Biol·2008
7-preclinical
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
PMID 17617280·Clin Ther·2007
4-observational
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
PMID 17631074·Am J Cardiol·2007
4-observational
Evaluation of the dose response with valsartan and valsartan/hydrochlorothiazide in patients with essential hypertension.
PMID 17268215·J Clin Hypertens (Greenwich)·2007
1-meta
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
PMID 17379047·Clin Ther·2007
4-observational
Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies.
PMID 17485971·J Clin Hypertens (Greenwich)·2007
4-observational
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
PMID 17493263·Genome Biol·2007
4-observational
Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
PMID 17586417·Am J Hypertens·2007
1-meta
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus.
PMID 17658623·Antiviral Res·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1526 W GLENDALE AVE, SUITE 101
PHOENIX, AZ 85021 - Phone
- (602) 277-5304
Quick Facts
- NPI
- 1497815542
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile